Form 4 for ASTH Astrana Health, Inc.
Accepted 2025-11-13 00:00:00 ET · period of report 2025-11-10 · accession 0001104659-25-111328 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-13 | 2025-11-10 | ASTH | Sim Kenneth T. | Executive COB, Dir | M - OptEx | $17.78 | +29.5K | 639.4K | +5% | +$524.5K |
| D | 2025-11-13 | 2025-11-10 | ASTH | Sim Kenneth T. | Executive COB, Dir | M - OptEx | $0.00 | -29.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-10 | M | A | 29,502 | $17.78 | 639,407 | D | — | — | (F6) Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 117,501 shares, which will vest in three equal annual installments beginning on March 5, 2026; and (ii) 133,333 shares, which will vest upon achievement of certain pre-established performance goals. |
| 2 | Derivative | Stock Option (right to buy) | 2025-11-10 | M | D | 29,502 | $0.00 | 0 | D | $17.78 · — to 2025-12-10 | 29,502 Common Stock | (F5) These stock options were fully vested and exercisable. |